Primer Highlights Risks of Direct-to-Consumer Antimicrobial Preparedness Kits

A primer in Clinical Infectious Diseases discusses risks associated with direct-to-consumer “emergency medical kits” containing prescription antimicrobials. According to the abstract, these kits are available online after limited medical screening and typically contain multiple antimicrobials intended for consumer-directed treatment of self-diagnosed infections. Although marketed as preparedness tools, the authors warn that use without appropriate clinical evaluation, diagnostic testing, or individualized dosing guidance may result in inappropriate indications, adverse drug effects, drug–drug interactions, incorrect dosing regimens, and unnecessary treatment courses. They also raise concerns that unsupervised access could reinforce misconceptions about appropriate antimicrobial use and contribute to antimicrobial resistance. The item addresses patient safety, antimicrobial stewardship, and public health rather than reporting measured clinical outcomes. Only the abstract was available for this update; it provides no sample size, quantitative risk estimates, or comparative outcome data.